387 related articles for article (PubMed ID: 24930711)
1. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.
Bahi A; Al Mansouri S; Al Memari E; Al Ameri M; Nurulain SM; Ojha S
Physiol Behav; 2014 Aug; 135():119-24. PubMed ID: 24930711
[TBL] [Abstract][Full Text] [Related]
2. The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, β-caryophyllene, in male mice.
Galdino PM; Nascimento MV; Florentino IF; Lino RC; Fajemiroye JO; Chaibub BA; de Paula JR; de Lima TC; Costa EA
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):276-84. PubMed ID: 22542869
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice.
Al Mansouri S; Ojha S; Al Maamari E; Al Ameri M; Nurulain SM; Bahi A
Pharmacol Biochem Behav; 2014 Sep; 124():260-8. PubMed ID: 24999220
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H₃ receptor antagonist ST-1283.
Bahi A; Schwed JS; Walter M; Stark H; Sadek B
Drug Des Devel Ther; 2014; 8():627-37. PubMed ID: 24920886
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice.
Tchekalarova J; da Conceição Machado K; Gomes Júnior AL; de Carvalho Melo Cavalcante AA; Momchilova A; Tzoneva R
Seizure; 2018 Apr; 57():22-26. PubMed ID: 29547827
[TBL] [Abstract][Full Text] [Related]
6. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682
[TBL] [Abstract][Full Text] [Related]
7. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
8. Hippocampus-specific deletion of tissue plasminogen activator "tPA" in adult mice impairs depression- and anxiety-like behaviors.
Bahi A; Dreyer JL
Eur Neuropsychopharmacol; 2012 Sep; 22(9):672-82. PubMed ID: 22377193
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression.
Hwang ES; Kim HB; Lee S; Kim MJ; Kim KJ; Han G; Han SY; Lee EA; Yoon JH; Kim DO; Maeng S; Park JH
Behav Brain Res; 2020 Feb; 380():112439. PubMed ID: 31862467
[TBL] [Abstract][Full Text] [Related]
10. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
Youssef DA; El-Fayoumi HM; Mahmoud MF
Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
[TBL] [Abstract][Full Text] [Related]
11. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: involvement of nitric oxide.
Pereira VS; Casarotto PC; Hiroaki-Sato VA; Sartim AG; Guimarães FS; Joca SR
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1769-78. PubMed ID: 23434291
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment.
Ebrahimi-Ghiri M; Nasehi M; Zarrindast MR
Behav Brain Res; 2019 May; 364():296-302. PubMed ID: 30797851
[TBL] [Abstract][Full Text] [Related]
15. Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors.
García-Gutiérrez MS; Pérez-Ortiz JM; Gutiérrez-Adán A; Manzanares J
Br J Pharmacol; 2010 Aug; 160(7):1773-84. PubMed ID: 20649579
[TBL] [Abstract][Full Text] [Related]
16. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
Kamble M; Gupta R; Rehan HS; Gupta LK
Eur J Pharmacol; 2016 Mar; 774():64-70. PubMed ID: 26849938
[TBL] [Abstract][Full Text] [Related]
17. Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.
García-Gutiérrez MS; García-Bueno B; Zoppi S; Leza JC; Manzanares J
Br J Pharmacol; 2012 Feb; 165(4):951-64. PubMed ID: 21838753
[TBL] [Abstract][Full Text] [Related]
18. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
Cheng Y; Dong Z; Liu S
Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
[TBL] [Abstract][Full Text] [Related]
19. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.
Mombereau C; Kaupmann K; Froestl W; Sansig G; van der Putten H; Cryan JF
Neuropsychopharmacology; 2004 Jun; 29(6):1050-62. PubMed ID: 15039762
[TBL] [Abstract][Full Text] [Related]
20.
Aguilar-Ávila DS; Flores-Soto ME; Tapia-Vázquez C; Pastor-Zarandona OA; López-Roa RI; Viveros-Paredes JM
J Med Food; 2019 May; 22(5):460-468. PubMed ID: 30864870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
